L-Carnitine w/ Fucoxanthin can help support you along the way.* Amplify fat burning with L-Carnitine w/ Fucoxanthin!* *These statements have not been evaluated by The Food and Drug Administration
Pochini et al., 2019
Obesity and overweight, which are common in patients with DM2, are a factors that favor the development/progression of CKD through both direct and indirect effects.69 Although the precise mechanisms the association between obesity and CKD are not totally defined it has been proposed that hypertension, glomerular hyperfiltration, hyperglycemia, lipid toxicity, inflammation or the role of adipose tissue and its adipokines are involved.70 Weight reduction by bariatric surgery, pharmacological treatment or dietary measures are associated with a nephroprotective effect,7173 so that weight reduction is a fundamental objective in the nephroprotection of patients with DKD
GLP-1 and GIP options may include Tirzepatide, Semaglutide, Mounjaro, Zepbound, Wegovy, and Ozempic when clinically appropriate
Researchers at Washington State University Health Sciences in Spokane, in collaboration with colleagues at Bastyr University Research Institute in Seattle, the Michael J
T., Stables, C